Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183066 · ClinicalTrials.gov registry record
Collection of Bone Marrow Aspirate From Volunteer Donors
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 63
- Enrollment target
NCT00183066: Completed study, sponsored by National Institute on Aging (NIA).
NCT00183066 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183066 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to collect bone marrow cells for research purposes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2002-07 |
| Est. Completion | 2012-08 |
What the finished NCT00183066 record still lists
NCT00183066 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00183066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00183066 about?
NCT00183066 is a clinical study titled "Collection of Bone Marrow Aspirate From Volunteer Donors". The purpose of this study is to collect bone marrow cells for research purposes.
What is the current status of trial NCT00183066?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2002-07. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT00183066?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia